Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
64.5M
-
Shares change
-
-2.03M
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
-$115M
-
Put/Call ratio
-
1.26
-
Number of buys
-
109
-
Number of sells
-
-87
-
Price
-
$35.00
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q3 2020
255 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2020.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.5M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.91M shares), VANGUARD GROUP INC (5.51M shares), BlackRock Inc. (4.8M shares), Bellevue Group AG (4.15M shares), FMR LLC (3.83M shares), Capital International Investors (3.44M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.11M shares), ORBIMED ADVISORS LLC (2.21M shares), GOLDMAN SACHS GROUP INC (2.19M shares), and STATE STREET CORP (2.07M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.